Press releases and articles
Options Exercised by Takeda and AI Collaboration Extended
Recursion Signs Global Licensing Agreement
Recursion Secures $1.6M NIH Phase 2 SBIR Grant to Identify Therapeutic Candidates for Senescence, a Key Age-Related Disease Process
Ron Alfa at AI in Healthcare, WPM18
Data Science Meetup: Lindsay (Anderson) Zuloaga
Blogs and Publications
This section provides resources and assets for media partners and journalists looking for background information about Recursion Pharmaceuticals. In this section, you will find corporate descriptions, biographies of our founders, approved images, and logos. There are many stories to tell about our innovative approach to drug discovery. We welcome you to use this information as a starting point in your story development and reach out to us for interviews and specific details related to your areas of interest.